The American Cancer Society released updated guidelines for colorectal cancer screening, adding options for a blood-based ...
The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...
Colon cancer is now the number one cancer killer in the U.S. of people ages 50 and younger, and yet many folks (at any age) are reluctant to get a colonoscopy -- the gold standard for detection of ...
The American Cancer Society updates colorectal cancer screening guidelines to improve access and participation, emphasizing ...
The American Cancer Society updated its colorectal cancer screening guidelines May 27 to include new blood- and stool-based screening options, while making clear that the blood-based test is a last ...
Researchers have long suspected that the gut microbiome – the community of bacteria and other microorganisms living in the ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of ColoSense®, the only RNA-based at-home test for colorectal ...
All patients diagnosed with early-onset colorectal cancer (EOCRC) should undergo germline multigene panel testing, as recommended by current National Comprehensive Cancer Network guidelines, to inform ...
As of July 1, Ontario will offer publicly funded colorectal cancer (CRC) screening to patients as young as 45 years. Patients ...
The approach enabled the researchers to establish a colorectal cancer microbiome signature that was not limited to one cohort, geography, sequencing method, or age of diagnosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results